RACHEL WITT: Open Payments
NPI 1295343358 · ATHENS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,229 in 191 payments from 18 companies in 2025. Trend: 2023 $1,019 · 2024 $1,939 · 2025 $2,229
Food & beverage: $2,224Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 60 | $472 |
| Janssen Biotech, Inc. | 26 | $355 |
| Regeneron Healthcare Solutions, Inc. | 13 | $252 |
| UCB, Inc. | 16 | $221 |
| Arcutis Biotherapeutics, Inc. | 26 | $207 |
| Amgen Inc. | 9 | $153 |
| Novartis Pharmaceuticals Corporation | 9 | $139 |
| MAYNE PHARMA COMMERCIAL LLC | 14 | $93 |
| LEO Pharma Inc. | 4 | $87 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $70 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Bimzelx, Zoryve, RINVOQ, OTEZLA, COSENTYX.
Industry payments across OH — which companies pay providers there.
